IMMUNE-MEDIATED ADVERSE REACTION

This adverse event was reported 1536 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED ADVERSE REACTION:

# Drug Count
0 NIVOLUMAB 183
1 ENFORTUMAB VEDOTIN 126
2 IPILIMUMAB 121
3 CARBOPLATIN 111
4 BEVACIZUMAB 86
5 PACLITAXEL 78
6 PEMETREXED DISODIUM 58
7 DURVALUMAB 57
8 TACROLIMUS 37
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 35
See all common drugs associated with IMMUNE-MEDIATED ADVERSE REACTION

IMMUNE-MEDIATED ADVERSE REACTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ENFORTUMAB VEDOTIN 126 0.0160
1 ONTRUZANT 8 0.0153
2 CROVALIMAB 1 0.0083
3 PLATINUM 4 0.0075
4 TREMELIMUMAB 24 0.0054
5 TEBENTAFUSP 3 0.0050
6 TALIMOGENE LAHERPAREPVEC 7 0.0044
7 CEMIPLIMAB-RWLC 8 0.0038
8 IPILIMUMAB 121 0.0028
9 DURVALUMAB 57 0.0026
See all drugs enriched for association with IMMUNE-MEDIATED ADVERSE REACTION